Mersana Therapeutics, Inc.(NasdaqGS:MRSN) dropped from S&P Biotechnology Select Industry Index
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.535 USD | -8.48% | -2.30% | +9.91% |
May. 09 | Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.91% | 339M | |
+7.81% | 115B | |
+12.90% | 107B | |
-13.55% | 22.31B | |
-3.99% | 21.6B | |
-6.59% | 18.23B | |
-39.93% | 17.62B | |
+6.93% | 14.26B | |
+33.06% | 12.37B | |
-28.05% | 8.28B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Mersana Therapeutics, Inc.(NasdaqGS: MRSN) dropped from S&P Biotechnology Select Industry Index